6Kinoshita H,Kobayashi K,Yaguramaki T, et al.Losartan potassium/ hydrochlorothiazide (Preminent) and hyponatremia: case series of 40 patients[J].Hum Exp Toxicol,2011,30(9): 1409-1414.
7Jia JY, Zhang MQ,Liu YM,et al.Pharmacokinetics and Bioequival- ence Evaluation of Two Losartan Potassium 50-mg Tablets: A Single-Dose, Randomized-Sequence, Open-Label, Two-Way Crossover Study in Healthy Chinese Male Volunteers[J].Clin Ther, 2010,32(7):1387-1395.
8Ohtawa M,Takayama F, Saitoh K,et al.Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an oratly active nonpeptide angiotensin II receptor antagonist, in humans[J].Br J Clin Pharmacol,1993,35(3): 290-297.
9Oliveira CH,Medeiros Silva R,Santagada V, et al.Comparative bioavailability of two losartan formulations in healthy human volunteers after a single dose administration[J].Int J Clin Pharm- acol Ther,2006,44(3): 142- 148.
10Tamimi JJI,Salem II,Mahmood Alam S,et al.Comparative Pharm- acokinetics of Two Tablet Formulations of Losartan: Bioequiva- lence Assessment[J].Biopharmac Drug Dispositin,2005,26(5):205- 210.
